Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial is studying how well Bowman-Birk inhibitor concentrate works
in preventing cancer in patients with oral leukoplakia. Chemoprevention is the use of certain
substances to keep cancer from forming, growing, or coming back. The use of Bowman-Birk
inhibitor concentrate, a substance made from soy, may keep cancer from forming in patients
with oral leukoplakia